December 10, 2013
Santen Pharmaceutical announced on December 6 that its European subsidiary in France, Santen S.A.S., submitted on December 5 a marketing authorization application (MAA) for its dry eye disease treatment ciclosporin (brand name in Europe: Ikervis) with the European Medicines Agency...read more